BIOHARVEST SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.24 CAD | +2.13% |
|
-5.88% | +11.63% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 5.5M 7.52M | Sales 2023 | 12.67M 17.32M | Capitalization | 77.63M 106M |
|---|---|---|---|---|---|
| Net income 2022 | -11M -15.04M | Net income 2023 | -12M -16.4M | EV / Sales 2022 | 19.5 x |
| Net Debt 2022 | 8.82M 12.06M | Net Debt 2023 | 16.99M 23.22M | EV / Sales 2023 | 7.47 x |
| P/E ratio 2022 |
-8.7
x | P/E ratio 2023 |
-6.11
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.87% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.13% | ||
| 1 week | -5.88% | ||
| 1 month | -4.00% | ||
| 3 months | +6.67% | ||
| 6 months | +50.00% | ||
| Current year | +11.63% |
1 week
0.23
0.26
1 month
0.230.26
Current year
0.200.30
1 year
0.140.30
3 years
0.140.54
5 years
0.100.71
10 years
0.100.71
| Managers | Title | Age | Since |
|---|---|---|---|
Ilan Sobel
CEO | Chief Executive Officer | - | 20-06-08 |
Alan Rootenberg
DFI | Director of Finance/CFO | 72 | 18-10-08 |
Zaki Rakib
CHM | Chairman | 66 | 18-09-26 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Ryan
BRD | Director/Board Member | 57 | 13-04-18 |
Zaki Rakib
CHM | Chairman | 66 | 18-09-26 |
David Tsur
BRD | Director/Board Member | 73 | 21-10-20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 0.24 | +2.13% | 11,150 |
| 24-05-09 | 0.235 | -2.08% | 5,500 |
| 24-05-08 | 0.24 | 0.00% | 17,054 |
| 24-05-06 | 0.24 | -5.88% | 173,591 |
| 24-05-03 | 0.255 | -1.92% | 65,530 |
Delayed Quote Canadian Securities Exchange, May 10, 2024 at 03:49 pm EDT
More quotes
BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.
Sector
Food Processing
Calendar
2024-05-27
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +11.63% | 101M | |
| +16.80% | 8.43B | |
| +15.02% | 6.82B | |
| -4.77% | 3.77B | |
| -6.75% | 3.74B | |
| +4.41% | 1.44B | |
| -30.34% | 1.06B | |
| +20.28% | 1.04B | |
| -12.85% | 890M | |
| -15.63% | 812M |
- Stock Market
- Equities
- BHSC Stock
